A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV
Status:
COMPLETED
Trial end date:
2025-06-16
Target enrollment:
Participant gender:
Summary
To evaluate the safety, efficacy, pharmacokinetic (PK) characteristics and antiviral activity of different doses of Deuterium Hydrobromide for suspension in the treatment of respiratory syncytial virus infection in infants.